Loading…
Misonix Inc. entered into a definitive agreement to acquire Solsys Medical LLC in an all-stock transaction valued at approximately $97 million, including assumption of $20 million in secured debt.
Misonix, Inc. has entered into a definitive agreement to acquire Solsys Medical, LLC, a regenerative medical company, in an all-stock transaction valued at approximately $97 million. The combined entity is expected to generate over $80 million in annual revenue for fiscal 2020.